The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
400 jobs Number of planned job creations
Announcement Date
27 August 2020
Employment effect (start)
27 August 2020
Foreseen end date
Description
Biopharma pharmaceutical company Regeneron is to create 400 new jobs at its plant in Limerick.
The new roles are in commercial manufacturing, process sciences, quality assurance/control, supply chain and various support functions for scientists, chemists and technicians.
Regeneron already employs around 1,000 people in Ireland. The company, operating in Ireland since 2015, has invested over €850m to make its manufacturing plant, the former Dell company site, the largest bulk biologics facility in Ireland.
The company is also involved in developing treatment for COVID-19.
Eurofound (2020), Regeneron, Business expansion in Ireland, factsheet number 101554, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/101554.